Saved source record
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.
This is a source-metadata record last found in a complete check on Sep 24, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: Exact-ID Europe PMC status checked Sep 25, 2026. No retraction or correction publication-type marker was listed in that response. This does not rule out other updates.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Human
- Published
- 2019 Dec
- Authors
- Stanley TL, Fourman LT, Feldpausch MN, Purdy J, Zheng I, Pan CS, Aepfelbacher J, Buckless C
- Journal or registry
- The lancet. HIV
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- Not reported in source metadata
- Identifiers
- DOI: 10.1016/S2352-3018(19)30338-8 · PMID: 31611038 · PMCID: PMC6981288
- First found
- Sep 24, 2026
- Last found
- Sep 24, 2026
Original sources
Browse saved studies · Search live sources